242
Views
22
CrossRef citations to date
0
Altmetric
Research Article

Exogenous galanin attenuates spatial memory impairment and decreases hippocampal beta-amyloid levels in rat model of Alzheimer's disease

, &
Pages 759-765 | Received 23 Jan 2013, Accepted 26 Apr 2013, Published online: 17 Jun 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Krista Freimann, Kaido Kurrikoff & Ülo Langel. (2015) Galanin receptors as a potential target for neurological disease. Expert Opinion on Therapeutic Targets 19:12, pages 1665-1676.
Read now

Articles from other publishers (21)

Estela Díaz-Sánchez, Alexander López-Salas, Marina Mirchandani-Duque, Jose Erik Alvarez-Contino, Jose Andrés Sánchez-Pérez, Kjell Fuxe, Dasiel O. Borroto-Escuela, Natalia García-Casares & Manuel Narváez. (2023) Decreased medial prefrontal cortex activity related to impaired novel object preference task performance following GALR2 and Y1R agonists intranasal infusion. Biomedicine & Pharmacotherapy 161, pages 114433.
Crossref
Marina Mirchandani-Duque, Miguel A. Barbancho, Alexander López-Salas, Jose Erik Alvarez-Contino, Natalia García-Casares, Kjell Fuxe, Dasiel O. Borroto-Escuela & Manuel Narváez. (2022) Galanin and Neuropeptide Y Interaction Enhances Proliferation of Granule Precursor Cells and Expression of Neuroprotective Factors in the Rat Hippocampus with Consequent Augmented Spatial Memory. Biomedicines 10:6, pages 1297.
Crossref
Dasiel O. Borroto-Escuela, Ramón Fores, Mariana Pita, Miguel A. Barbancho, Pablo Zamorano‐Gonzalez, Natalia García Casares, Kjell Fuxe & Manuel Narváez. (2022) Intranasal Delivery of Galanin 2 and Neuropeptide Y1 Agonists Enhanced Spatial Memory Performance and Neuronal Precursor Cells Proliferation in the Dorsal Hippocampus in Rats. Frontiers in Pharmacology 13.
Crossref
A. S. Alexandris, L. Walker, A. K. L. Liu, K. E. McAleese, M. Johnson, R. K. B. Pearce, S. M. Gentleman & J. Attems. (2019) Cholinergic deficits and galaninergic hyperinnervation of the nucleus basalis of Meynert in Alzheimer’s disease and Lewy body disorders. Neuropathology and Applied Neurobiology 46:3, pages 264-278.
Crossref
Pedro Merino. 2019. Chemical Biology of Neurodegeneration. Chemical Biology of Neurodegeneration 41 80 .
Mahnaz Taherianfard & Diaco Shahmoradi. (2018) Effect of Intrahippocampal CA3 Injection of Spexin on Passive Avoidance Learning and Memory in Normal and Castrated Rats. Archives of Neuroscience 5:2.
Crossref
Stéphane Peineau, Kevin Rabiant, Olivier Pierrefiche & Brigitte Potier. (2018) Synaptic plasticity modulation by circulating peptides and metaplasticity: Involvement in Alzheimer’s disease. Pharmacological Research 130, pages 385-401.
Crossref
Penghua Fang, Mei Yu, Dang Wan, Lei Zhang, Long Han, Zhongqi Shen, Mingyi Shi, Yan Zhu, Zhenwen Zhang & Ping Bo. (2017) Regulatory effects of galanin system on development of several age-related chronic diseases. Experimental Gerontology 95, pages 88-97.
Crossref
Yutao Yang, Li Liu, Hanjiang Luo, Yueting Li, Hui Li & Zhi-Qing David Xu. (2016) Characterization of the Rat GAL2R Promoter: Positive Role of ETS-1 in Regulation of the Rat GAL2R Gene in PC12 Cells. Molecular Neurobiology 54:6, pages 4421-4431.
Crossref
Joanne C. Damborsky, Kathleen G. Smith, Patricia Jensen & Jerrel L. Yakel. (2016) Local cholinergic-GABAergic circuitry within the basal forebrain is modulated by galanin. Brain Structure and Function 222:3, pages 1385-1400.
Crossref
Yun Li, Zhu Mei, Shuiqiao Liu, Tong Wang, Hui Li, Xiao-Xiao Li, Song Han, Yutao Yang, Junfa Li & Zhi-Qing David Xu. (2017) Galanin Protects from Caspase-8/12-initiated Neuronal Apoptosis in the Ischemic Mouse Brain via GalR1. Aging and disease 8:1, pages 85.
Crossref
Izabela Sadowska-Bartosz & Grzegorz Bartosz. (2016) Effect of glycation inhibitors on aging and age-related diseases. Mechanisms of Ageing and Development 160, pages 1-18.
Crossref
F.R.C. Soares, G.P. Silote, A.F. Almeida-Santos, D.C. Aguiar, L.C. Schenberg & V. Beijamini. (2016) Galanin microinjection into the dorsal periaqueductal gray matter produces paradigm-dependent anxiolytic effects. Brain Research Bulletin 121, pages 42-47.
Crossref
Kiyoshi Misawa, Yuki Misawa, Takeharu Kanazawa, Daiki Mochizuki, Atsushi Imai, Shiori Endo, Thomas E. Carey & Hiroyuki Mineta. (2015) Epigenetic inactivation of galanin and GALR1/2 is associated with early recurrence in head and neck cancer. Clinical & Experimental Metastasis 33:2, pages 187-195.
Crossref
Xiao-feng Xu, Dan-dan Zhang, Jin-chi Liao, Li Xiao, Qing Wang & Wei Qiu. (2016) Galanin and its receptor system promote the repair of injured sciatic nerves in diabetic rats. Neural Regeneration Research 11:9, pages 1517.
Crossref
Zhenwen Zhang, Penghua Fang, Mingyi Shi, Yan Zhu & Ping Bo. (2015) Elevated galanin may predict the risk of type 2 diabetes mellitus for development of Alzheimer’s disease. Mechanisms of Ageing and Development 150, pages 20-26.
Crossref
G. Barreda-Gómez, L. Lombardero, M.T. Giralt, I. Manuel & R. Rodríguez-Puertas. (2015) Effects of galanin subchronic treatment on memory and muscarinic receptors. Neuroscience 293, pages 23-34.
Crossref
Yong Cheng & Long-Chuan Yu. (2015) Galanin up-regulates the expression of M1 muscarinic acetylcholine receptor via the ERK signaling pathway in primary cultured prefrontal cortical neurons. Neuroscience Letters 590, pages 161-165.
Crossref
Roland Lang, Andrew L. Gundlach, Fiona E. Holmes, Sally A. Hobson, David Wynick, Tomas Hökfelt & Barbara Kofler. (2014) Physiology, Signaling, and Pharmacology of Galanin Peptides and Receptors: Three Decades of Emerging Diversity. Pharmacological Reviews 67:1, pages 118-175.
Crossref
Ramón Cacabelos, Pablo Cacabelos, Clara Torrellas, Iván Tellado & Juan C. Carril. 2014. Pharmacogenomics in Drug Discovery and Development. Pharmacogenomics in Drug Discovery and Development 323 556 .
Éva Borbély, Bálint Scheich & Zsuzsanna Helyes. (2013) Neuropeptides in learning and memory. Neuropeptides 47:6, pages 439-450.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.